Skip to main content
. 2013 Mar 19;8:64. doi: 10.1186/1748-717X-8-64

Table 4.

Clinical outcomes

Endpoint Time (months)
Median follow-up, living patients
11.1
Median survival
10.6
Median local control
41.5
Distant Intracranial Failure
 
Median DIF, all patients
17.3
Median DIF, progressive disease
6.2
Median DIF, stable disease
Not reached
1-year outcomes
% Survival
1-year actuarial OS
47.9%
1-year actuarial LC
89.1%
1-year actuarial DIF 61.2%